Gwo-Yaw Ho

Dr. Gwo-Yaw Ho is a medical oncologist and clinician-scientist at Monash University, leading the Cancer Immunology Laboratory within the School of Clinical Sciences. He holds a Research Fellowship at Monash Health and is actively involved in clinical oncology, treating breast and gynaecologic cancers. His research focuses on immunotherapy innovations, including neoantigen-based T-cell receptor therapies and MYCN pathway-driven ovarian cancer mechanisms.

Education:

• PhD in Cancer Research (2019), Walter and Eliza Hall Institute
• MBChB (2004), University of Glasgow
• BSc (Honours) in Molecular and Cellular Biology (2002), University of Glasgow

Research Interests:

• Developing neoantigen identification platforms for personalized immunotherapy
• MYCN pathway activation in high-grade serous ovarian cancer (HGSOC)
• Preclinical models for novel therapeutics targeting refractory cancers

Recent Projects:

• Interferon epsilon immunotherapy for ovarian cancer (US DOD-funded)
• Phase 2 trials of antibody-drug conjugates (e.g., CATALINA-2, GLORIOSA)

Awards:

• RACP Foundation Research Fellowship
• Tour de Cure Grant

Grants & Collaborations:

• Collaborations with institutions like Peter MacCallum Cancer Centre and US Army Medical Research
• Funding from DOD, RACP, and industry partners

Labs/Teams: Leads the Cancer Immunology Laboratory at Monash University, integrating clinical practice with translational research.